DKCM
WGSWW

Davidson Kempner Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Davidson Kempner Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-84,234
Closed -$381K – 586
2021
Q2 		$381K Sell
84,234
-102,615
-55% -$439K ﹤0.01% 429
2021
Q1 		$912K Buy
+186,849
New +$1.04M 0.01% 354

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Davidson Kempner Capital Management's WGSWW Position: Q3 2021 in Review

Davidson Kempner Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2021, closing a stake of 84,234 shares — an estimated $381K sold.

Davidson Kempner Capital Management first reported a position in WGSWW in Q1 2021 and held it in 2 quarters. The position peaked at $912K in Q1 2021. 35 funds tracked by Wall St. Rank hold WGSWW as of Q3 2021.

  • Davidson Kempner Capital Management reported no remaining GeneDx Holdings Warrant position as of Q3 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 84,234 GeneDx Holdings Warrant shares in Q3 2021, an estimated $381K.
  • Davidson Kempner Capital Management first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 2 quarters.
  • Davidson Kempner Capital Management's GeneDx Holdings Warrant position peaked at $912K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.